Nano-Emulsified Perfluorooctyl Bromide Can Infiltrate Gram-Negative Bacteria and Sensitize Them to Ultrasound
Source abstract
Abstract
Gram-negative (G-) bacterial infections remain one of the most urgent global health threats, because the distinctive envelope structure hinders the penetration of therapeutics. Here, we showed that a perfluorooctyl bromide nanoemulsion (PFOB NE) uniquely interacts with G- bacteria. After cell envelope attachment, the PFOB can infiltrate the cell and was diffused throughout. In this process, it impaired the membranes by disintegrating phospholipid molecules, enhancing the consequent ultrasonic cavitation to break the envelope. We identified through ultrasound that the NE had remarkable bactericidal effects against various antibiotic-resistant pathogens. Using in situ sterilization, this approach accelerated the recovery of bacteria-infected murine skin wounds. Thus, combining PFOB and ultrasound might be an alternative tool for conquering the growing threat of G- pathogens.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Lab of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, P. R. China
Shanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, P. R. China
Funding
National Natural Science Foundation of China
References (61)
Show source-provided references
1. 10.1001/jama.2009.175410.1001/jama.2009.1754 ↗
2. 10.1016/S1473-3099(17)30753-310.1016/S1473-3099(17)30753-3 ↗
3. 10.1086/66877010.1086/668770 ↗
4. 10.1086/50796210.1086/507962 ↗
5. China Antimicrobial Resistance Surveillance System. National Health Commission of the PRC. http://www.carss.cn/ (accessed 2023-12-19).
6. China Antimicrobial Surveillance Network. Antibiotic Research Institute of Huashan Hospital Affiliated to Fudan University. https://www.chinets.com/ (accessed 2023-12-19).
7. 10.1111/nyas.1413410.1111/nyas.14134 ↗
8. 10.1021/acsinfecdis.5b0009710.1021/acsinfecdis.5b00097 ↗
9. 10.1038/nmicrobiol.2017.110.1038/nmicrobiol.2017.1 ↗
10. 10.1002/phar.163610.1002/phar.1636 ↗
11. 10.1021/jm201275d10.1021/jm201275d ↗
12. 10.1016/j.addr.2020.12.01610.1016/j.addr.2020.12.016 ↗
13. 10.1128/AEM.00453-0810.1128/AEM.00453-08 ↗
14. 10.1021/ja045664d10.1021/ja045664d ↗
15. 10.1021/ja801662y10.1021/ja801662y ↗
16. 10.1021/bi00164a01710.1021/bi00164a017 ↗
17. 10.1021/bi982629910.1021/bi9826299 ↗
18. 10.1128/AAC.24.1.11410.1128/AAC.24.1.114 ↗
19. 10.1128/MMBR.67.4.593-656.200310.1128/MMBR.67.4.593-656.2003 ↗
20. 10.1021/acsnano.1c1101310.1021/acsnano.1c11013 ↗
21. 10.1146/annurev.ph.28.030166.00225110.1146/annurev.ph.28.030166.002251 ↗
22. 10.1111/1574-6976.1202610.1111/1574-6976.12026 ↗
23. 10.1371/journal.pone.021180310.1371/journal.pone.0211803 ↗
24. 10.1002/smll.20160032710.1002/smll.201600327 ↗
25. 10.3390/microorganisms1005092410.3390/microorganisms10050924 ↗
26. 10.1038/nmicrobiol.2016.16210.1038/nmicrobiol.2016.162 ↗
27. 10.1126/science.abf811310.1126/science.abf8113 ↗
28. 10.1021/acs.nanolett.9b0205310.1021/acs.nanolett.9b02053 ↗
29. 10.1016/j.bios.2013.01.01410.1016/j.bios.2013.01.014 ↗
30. 10.1016/j.biomaterials.2005.05.00710.1016/j.biomaterials.2005.05.007 ↗
31. 10.1007/s12274-015-0929-110.1007/s12274-015-0929-1 ↗
32. 10.1295/polymj.8.20210.1295/polymj.8.202 ↗
33. 10.1021/ja01029a05810.1021/ja01029a058 ↗
34. 10.1007/s00418-008-0509-510.1007/s00418-008-0509-5 ↗
35. 10.1016/j.jpba.2013.09.00310.1016/j.jpba.2013.09.003 ↗
36. 10.1002/adma.20140063610.1002/adma.201400636 ↗
37. 10.1021/acsami.5b1268810.1021/acsami.5b12688 ↗
38. 10.1016/j.aca.2017.09.04610.1016/j.aca.2017.09.046 ↗
39. 10.1038/srep2804510.1038/srep28045 ↗
40. 10.1128/AAC.06327-1110.1128/AAC.06327-11 ↗
41. 10.1159/00006977210.1159/000069772 ↗
42. 10.1021/acs.biomac.9b0140110.1021/acs.biomac.9b01401 ↗
43. 10.1016/j.cej.2020.12488810.1016/j.cej.2020.124888 ↗
44. 10.1002/btm2.1014910.1002/btm2.10149 ↗
45. 10.1159/00049532010.1159/000495320 ↗
46. 10.1002/advs.20217005010.1002/advs.202170050 ↗
47. Li Y. · Zhongguo yi xue ke xue Yuan xue bao. Acta Academiae Medicinae Sinicae · 2017 · 39 · 301
48. 10.1089/pho.2009.260110.1089/pho.2009.2601 ↗
49. 10.1097/00001432-200404000-0000410.1097/00001432-200404000-00004 ↗
50. 10.1002/adfm.20180214010.1002/adfm.201802140 ↗
51. 10.1002/anie.20180497110.1002/anie.201804971 ↗
52. 10.1055/s-0039-169399510.1055/s-0039-1693995 ↗
53. 10.1016/j.ultsonch.2011.02.00110.1016/j.ultsonch.2011.02.001 ↗
54. 10.1002/adfm.20211106610.1002/adfm.202111066 ↗
55. Riess, J. Fluorocarbon-Based Blood Substitutes: What Progress?; SAGE Publications: London, 1991; Vol. 14, pp 255–258.10.1177/039139889101400501 ↗
56. 10.1148/radiol.1009233910.1148/radiol.10092339 ↗
57. 10.1016/j.biomaterials.2017.04.00610.1016/j.biomaterials.2017.04.006 ↗
58. 10.1016/j.biomaterials.2018.02.04110.1016/j.biomaterials.2018.02.041 ↗
59. 10.1056/NEJM19960912335110110.1056/NEJM199609123351101 ↗
60. 10.1111/j.1525-1594.2009.00944.x10.1111/j.1525-1594.2009.00944.x ↗
61. 10.1002/advs.20180004910.1002/advs.201800049 ↗